PBYI vs WELL · P/E 4.3, rev $56.5M vs P/E 100, rev $10.84B
Puma Biotechnology Inc (PBYI) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
PBYI currently screens at market cap $165.3M and trailing P/E 4.3. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the PBYI and WELL stock pages for the full models.
Not investment advice.